2018年9月10日下午,正在成都出席“第五届诺贝尔奖获得者医学峰会暨全球生物医药创新大会”的国家新药筛选中心主任、87978797威尼斯老品牌院长王明伟研究员、东方高圣控股股份有限公司陈明键董事长和方恩医药发展有限公司张丹董事长登台与2003年诺贝尔化学奖得主Peter Agre教授、2004年诺贝尔化学奖得主Aaron Ciechanover教授、2009年诺贝尔化学奖得主Ada E. Yonath教授、2012年诺贝尔生理学或医学奖得主John B. Gurdon教授和2014年诺贝尔生理学或医学奖得主Edvard I. Moser教授互动交流,畅谈生物医药产业源头创新和可持续性发展的要素和路径。中国化学制药工业协会张自然副会长主持了这场高端对话活动。
Dr. Ming-Wei Wang attends a peak-level dialogue with five Nobel Prize laureates in Chengdu
In the afternoon of September 10, 2018, Dr. Ming-Wei Wang (Director, the National Center for Drug Screening and Dean, School of Pharmacy, Fudan University), Mr. James Chen (Chairman, Hollyhigh International Capital) and Dr. Dan Zhang (Chairman, Fountain Medical Development Ltd.) participated in a peak-level dialogue with Drs. Peter Agre (2003 Nobel Laureate in Chemistry), Aaron Ciechanover (2004 Nobel Laureate in Chemistry), Ada E. Yonath (2009 Nobel Laureate in Chemistry), John B. Gurdon (2012 Nobel Laureate in Physiology or Medicine) and Edvard I. Moser (2014 Nobel Laureate in Physiology or Medicine), covering topics such as key elements and critical paths for biopharmaceutical industry original innovation and sustainable development. The event was chaired by Mr. Zhiran Zhang (Vice President, China Pharmaceutical Industry Association) and is a main program of the ongoing 5th Nobel Laureate Science Summit and Global Biomedical Innovation Conference.